These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 11400112)

  • 1. Cyclin D1-CDK4 complex, a possible critical factor for cell proliferation and prognosis in laryngeal squamous cell carcinomas.
    Dong Y; Sui L; Sugimoto K; Tai Y; Tokuda M
    Int J Cancer; 2001 Jul; 95(4):209-15. PubMed ID: 11400112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of cyclin E overexpression in laryngeal squamous cell carcinomas.
    Dong Y; Sui L; Tai Y; Sugimoto K; Hirao T; Tokuda M
    Clin Cancer Res; 2000 Nov; 6(11):4253-8. PubMed ID: 11106240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G1/S-specific cyclin-D1 might be a prognostic biomarker for patients with laryngeal squamous cell carcinoma.
    Zhang YY; Xu ZN; Wang JX; Wei DM; Pan XL
    Asian Pac J Cancer Prev; 2012; 13(5):2133-7. PubMed ID: 22901182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of cyclin D1 and E-cadherin expression in laryngeal squamous cell carcinoma.
    Ahmed RA; Shawky Ael-A; Hamed RH
    Pathol Oncol Res; 2014 Jul; 20(3):625-33. PubMed ID: 24470282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The overexpression of cyclin-dependent kinase (CDK) 2 in laryngeal squamous cell carcinomas.
    Dong Y; Sui L; Tai Y; Sugimoto K; Tokuda M
    Anticancer Res; 2001; 21(1A):103-8. PubMed ID: 11299721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of cyclin D1 protein overexpression in laryngeal squamous cell carcinoma.
    Pignataro L; Pruneri G; Carboni N; Capaccio P; Cesana BM; Neri A; Buffa R
    J Clin Oncol; 1998 Sep; 16(9):3069-77. PubMed ID: 9738577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KAI1/CD82 and cyclin D1 as biomarkers of invasion, metastasis and prognosis of laryngeal squamous cell carcinoma.
    Zhang B; Liu W; Li L; Lu J; Liu M; Sun Y; Jin D
    Int J Clin Exp Pathol; 2013; 6(6):1060-7. PubMed ID: 23696923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of deregulated expression of cyclin D1 and cyclin E with that of cyclin-dependent kinase 4 (CDK4) and CDK2 in human oesophageal squamous cell carcinoma.
    Matsumoto M; Furihata M; Ishikawa T; Ohtsuki Y; Ogoshi S
    Br J Cancer; 1999 Apr; 80(1-2):256-61. PubMed ID: 10390005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant expression of cyclin A in laryngeal squamous cell carcinoma.
    Dong Y; Sui L; Watanabe Y; Sugimoto K; Tokuda M
    Anticancer Res; 2002; 22(1A):83-9. PubMed ID: 12017338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostics of Cyclin-D1 expression with chemoradiation response in patients of locally advanced oral squamous cell carcinoma.
    Khan H; Gupta S; Husain N; Misra S; Singh N; Negi MP
    J Cancer Res Ther; 2014; 10(2):258-64. PubMed ID: 25022375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of paxillin in laryngeal squamous cell carcinoma and its prognostic value.
    Li L; Wang J; Gao L; Gong L
    Int J Clin Exp Pathol; 2015; 8(8):9232-9. PubMed ID: 26464671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin-dependent kinase inhibitor p27 is related to cell proliferation and prognosis in laryngeal squamous cell carcinomas.
    Tamura N; Dong Y; Sui L; Tai Y; Sugimoto K; Nagahata S; Tokuda M
    J Laryngol Otol; 2001 May; 115(5):400-6. PubMed ID: 11410133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53, p16 and cyclin D1: molecular determinants of radiotherapy treatment response in oral carcinoma.
    Jayasurya R; Francis G; Kannan S; Lekshminarayanan K; Nalinakumari KR; Abraham T; Abraham EK; Nair MK
    Int J Cancer; 2004 May; 109(5):710-6. PubMed ID: 14999779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunolocalization of cyclins D and E and cyclin dependent kinase (cdk) 2 and 4 in human breast carcinoma.
    Sasano H; Frost AR; Saitoh R; Taniyama Y; Nagura H; Matsunaga G; Takehana K; Kimura M; Silverberg SG
    Anticancer Res; 1997; 17(5A):3685-90. PubMed ID: 9413224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx.
    Vielba R; Bilbao J; Ispizua A; Zabalza I; Alfaro J; Rezola R; Moreno E; Elorriaga J; Alonso I; Baroja A; de la Hoz C
    Laryngoscope; 2003 Jan; 113(1):167-72. PubMed ID: 12514403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
    J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-phase kinase-associated protein 2 expression in laryngeal squamous cell carcinomas and its prognostic implications.
    Dong Y; Sui L; Watanabe Y; Sugimoto K; Tokuda M
    Oncol Rep; 2003; 10(2):321-5. PubMed ID: 12579266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of cyclins, cyclin-dependent kinases, tumor-suppressor gene products, Ki-67, and sex steroid receptors in endometrial carcinoma: positive staining for cyclin A as a poor prognostic indicator.
    Shih HC; Shiozawa T; Kato K; Imai T; Miyamoto T; Uchikawa J; Nikaido T; Konishi I
    Hum Pathol; 2003 May; 34(5):471-8. PubMed ID: 12792921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of Jab1 expression in laryngeal squamous cell carcinomas.
    Dong Y; Sui L; Watanabe Y; Yamaguchi F; Hatano N; Tokuda M
    Clin Cancer Res; 2005 Jan; 11(1):259-66. PubMed ID: 15671554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical relevance of cyclin B1 overexpression in laryngeal squamous cell carcinoma.
    Dong Y; Sui L; Watanabe Y; Sugimoto K; Tokuda M
    Cancer Lett; 2002 Mar; 177(1):13-9. PubMed ID: 11809526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.